Hanalytics Pte Ltd (BioMind®) is a deeptech company specialising in healthcare. The company builds advanced AI technology and creates predictive applications to assist doctors diagnose medical conditions and recommend treatments. The company has a strong team of over 60 in-house deep learning scientists, medical experts, and research advisors from prestigious hospitals and universities.
In December 2018, BioMind® establish the world’s first and largest AI research centre for neurological diseases. The research centre, CNCRC-Hanalytics Artificial Intelligence Research Centre for Neurological Disorders (CHAIN), researches and develops AI applications covering a wide spectrum of areas including brain tumors, vascular diseases, genetics, patient rehabilitation, pathology amongst many other conditions.
Products & services
BioMind® is a state-of-the-art diagnostic support system that uses deep learning technology to analyse MRI and CT images. It automatically recommends a diagnosis and report for doctors to review – all within seconds. The efficiency gains are significant when compared to the usual 1 hour or more doctors usually take for analysis and reporting.
Technical / technological capabilities
BioMind® is jointly developed by over 200 world-renowned medical specialists and deep learning experts and trained on the earth’s largest collection of biopsy-validated images “the ground truth”. Its signature feature includes analysing neurological disorders such as brain tumours, vascular diseases and stroke-related medical conditions – which take up majority of the conditions determined through medical imaging With the application of AI technology, not only can BioMind® analyse a large spectrum of neurological conditions, its technology can also be upgraded to analyse medical conditions of other body systems. BioMind® also has sophisticated image processing features like image segmentation and 3D reconstruction to assist in surgeries.
Cleverly developed, BioMind® has the ability to self-learn and improve through cycles of predictions and doctors’ revisions. This ability in turns assists doctors to reduce misdiagnosis and blind spots and improve efficiency of medical processes.
Main customers / collaborations
BioMind®’s key customer that can be disclosed include Beijing Tiantan Hospital, a global leader in neurology and neurosurgery. BioMind® is being used in the radiology and A&E department for tumour and stroke detection and diagnoses.
Print this page Send by email